THE MODERN LIVING PEACE TRAIN™
Checking your passage…
One moment while your discovery opens.
MASLD: essential context
Sources and review scope
These source notes explain the evidence consulted and its limits. Educational information does not replace individual medical care.
- TMLPT-CATALOGUE-NOV2
- TMLPT public Orange catalogue
TMLPT destination for contextual exploration; not external clinical evidence. · Used for the identified educational claims. Source-based editorial checking is distinct from independent clinical review, which has not been completed.
Contextual destination, not evidence that following the link prevents or treats a condition.
- TMLPT-RECIPES-NOV2
- TMLPT public Kitchen—preparation context
TMLPT destination for contextual exploration; not external clinical evidence. · Used for the identified educational claims. Source-based editorial checking is distinct from independent clinical review, which has not been completed.
Contextual destination, not evidence that following the link prevents or treats a condition.
- lv-care
- NIDDK Treatment for NAFLD & NASH
How do doctors treat NAFLD?; Medicines; complications of NASH · Used for the identified educational claims. Source-based editorial checking is distinct from independent clinical review, which has not been completed.
Reviewed April 2021. Its statement that no medicines are approved is outdated and is not used here. The citation supports only the identified lifestyle and supplement cautions.
- lv-diet
- NIDDK Eating Diet and Nutrition for NAFLD/NASH
How can my diet help prevent or treat NAFLD? · Used for the identified educational claims. Source-based editorial checking is distinct from independent clinical review, which has not been completed.
Reviewed April 2021. Older nutrition education; not authority for current medicine indications.
- lv-emergency
- NHS Cirrhosis
Urgent advice; Immediate action required; support team · Used for the identified educational claims. Source-based editorial checking is distinct from independent clinical review, which has not been completed.
A review date of 10 February 2025 was recorded previously; the current footer date was not confirmed. The emergency guidance concerns cirrhosis and is not a diagnostic test for MASLD.
- lv-guideline
- EASL–EASD–EASO MASLD guideline
PDF pp 1–2 Introduction/Preamble; pp 8–9 non-invasive assessment; p 18 surrogate outcomes; pp 19–22 lifestyle; p 34 research gaps · Used for the identified educational claims. Source-based editorial checking is distinct from independent clinical review, which has not been completed.
July 2024 guideline using the nomenclature established in June 2023. Its treatment landscape predates later semaglutide authorization. The full recommendations and disclosures have not been comprehensively appraised.
- lv-fda-2025
- FDA: MASH approval announcement
Action; Disease or Condition; Data Supporting Wegovy · Used for the identified educational claims. Source-based editorial checking is distinct from independent clinical review, which has not been completed.
Historical approval announcement; not a check of the latest full prescribing information. No personal regimen or numerical efficacy claim is supplied.